TrialBritish journal of clinical pharmacology2024

Population pharmacokinetic/target engagement modelling of tozorakimab in healthy volunteers and patients with chronic obstructive pulmonary disease.

Muhammad Waqas Sadiq et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.